Previous 10 | Next 10 |
Oramed to Present at H.C. Wainwright 23rd Annual Global Investment Conference PR Newswire NEW YORK , Sept. 9, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused...
Gainers: Sphere 3D (NASDAQ:ANY) +50%. Data Storage (NASDAQ:DTST) +28%. Cloopen Group (NYSE:RAAS) +26%. Aurora Mobile (NASDAQ:JG) +21%. Liquid Media (NASDAQ:YVR) +21%. Globalstar (NYSE:GSAT) +20%. TSR (NASDAQ:TSRI) +19%. The L.S. Starrett (NYSE:SCX) +18%. Tiziana Life Sciences (NASDAQ:TLSA) +1...
Read the full story here: For further details see: Wall Street Breakfast: Ida Remnants Batter Northeast (Podcast)
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Wallet extinctionIn a major expansion of its app-based services, Apple (AAPL) has lined up the first U.S. states to allow drivers to store their licenses w...
Oramed Reaches 25% Enrollment in Its Second of Two Concurrent Phase 3 Oral Insulin Trials - ORA-D-013-2 is the second of two Phase 3 trials under FDA protocol currently underway - ORA-D-013-1, the larger and first of the 2-part trial to commence, nears 65% enrollment PR ...
Oramed Announces Publication of Oral Insulin Study in Peer-Reviewed Journal: Diabetes, Obesity, and Metabolism PR Newswire NEW YORK , Aug. 16, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP), (TASE: ORMP) ( www.oramed.com ), a clinical-stage p...
Lightning eMotors ZEV +44% on signing largest contract ever in the electric shuttle bus market with Forest River Fulcrum Therapeutics FULC +53% on early-stage results for sickle cell disease therapy IMV IMV +39% on promising maveropepimut-S data in ovarian cancer...
Shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) traded today at $20.37, eclipsing its 52-week high. This new high was reached on below average trading volume as 251,000 shares traded hands, while the average 30-day volume is approximately 784,000 shares. Oramed Pharmaceuticals Inc is...
Oramed to Present at Canaccord Genuity's 41st Annual Growth Conference PR Newswire NEW YORK , Aug. 9, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on the devel...
Sphere 3D Corp (NASDAQ:ANY) +43% agreement to acquire exclusive rights for assignment of cryptocurrency mining assets Kaixin Auto (NASDAQ:KXIN) +23% on foraying into new energy vehicle business Switch (NYSE:SWCH) +19% on Q2 earnings Westport Fuel (NASDAQ:WPRT) +1...
News, Short Squeeze, Breakout and More Instantly...
Oramed Pharmaceuticals Inc. Company Name:
ORMP Stock Symbol:
NASDAQ Market:
Oramed Pharmaceuticals Inc. Website:
PALO ALTO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today...
Crescent Energy Company Class A (CRGY) is expected to report $0.21 for Q4 2023 ThredUp Inc. (TDUP) is expected to report $-0.13 for Q4 2023 Wright Investors` Service Holdings Inc (IWSH) is expected to report for Q4 2023 Bridgford Foods Corporation (BRID) is expected to report for Q1 2...